Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

SUM '20 - Pharm II > Week 1 Antiepileptic 3 of 4 > Flashcards

Week 1 Antiepileptic 3 of 4 Flashcards

1
Q

Plasma protein binding of valproic acid?

A

> 80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

peak plasma concentration of valproic acid occurs in how many hours?

A

1-4 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What route is valproic acid known to have prompt absorption?

A

PO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Therapeutic plasma concentration of valproic acid is ?

A

50-100mcg/ml

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is a better determinant of valproic acids therapeutic concentration (compared to plasma concentration?)

A

clinical condition may be a better determinant of therapeutic concentration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the side effects of valproic acid?

A

anorexia n/v
fine distal tremor seen in higher doses
thrombocytopenia seen frequently at higher doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the issue with valproic acid and and children under 2 years of age?

A

Most serious side effect is hepatotoxicity occuring in around 0.2% of children 2 years old who are treated chronically. This is potentially fatal. Hepatic necrosis decreases dramatically after 2 years of age.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are two infrequent side effects with valproic acid? (you see these side effects with other seizure medications but not valproic acid)

A

sedation and ataxia is not seen with valproic acid.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Because this medication is partially eliminated as a ketone containing metabolite, may have a false positive ketone result, what medication does this describe?

A

valproic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What can valproic acid do to phenytoin and diazepam?

A

can displace phenytoin and diazepam from protein binding sites resulting in increased pharmacologic effects produced by displaced drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does valproic acid do to the plasma concentration of phenobarbital?

A

increases it by around 50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Does valproic acid interfere with the action of oral contraceptives?

A

NO!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is Parkinson’s dz and who does it effect?

A

Results from loss of dopaminergic neurons in the substantia nigra pars compacta region of basal ganglia.

Effects roughly 1% of population usually greater than 60 years old.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is a consistent feature found in the substantia nigra region of patient’s with parkinson’s dz?

A

Lewy Bodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what type of neurotransmitter is dopamine and acetylcholine?

A

dopamine is thought to act principally as an inhibitory NT.

acetylcholine is thought to be an excitatory NT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Where is roughly 80% of the dopamine in the brain found?

A

basal ganglia, mostly in the caudate nucleus and putamen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

In patient’s with Parkinson’s dz the basal ganglia content of dopamine may be as low as what?

A

10% of normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What happens to people who have super low dopamine in their brain?

A

an excess of excitatory cholinergic activity manifesting as progressive tremor, skeletal muscle rigidity, bradykinesia, and disturbances of posture result.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the objective in treatment of Parkinson’s dz?

A

to treat debilitating symptoms. Current meds are palliative and do not affect the progression of the dz. Treatments are selected based on age and severity of symptoms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

When is pharmacologic treatment started for a parkinson’s patient?

A

when motor symptoms become bothersome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Other than treatment aimed at addressing motor symptoms in Parkinson’s patients, treatment will also be addressing other adverse effects: what would these other adverse effects be?

A 
nausea
depression
autonomic disturbances
cognitive impairment
medication related side effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

True or False

Dopamine readily crosses the BBB?

A

False, it does NOT readily cross the BBB. This is why Levodopa is used (precursor to dopamine) because it can cross the BBB. Other drugs that mimic the action of dopamine can also be used.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is levodopa usually administered with?

A

a peripheral decarboxylase inhibitor (carbidopa or benserazide) This medication maximizes the entrance of levodopa into the brain before it is converted to dopamine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What medication is considered the cornerstone of symptomatic therapy for Parkinson’s dz?

A

Levodopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What converts levodopa to dopamine? (think enzyme)

A

L-amino-acid decarboxylase (dopa decxarboxylase enzyme)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What replenishes dopamine stores in the basal ganglia?

A

Levodopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Tell me what Decarboxylase inhibitor does?

A

maximize entrance of levodopa into the brain before its converted to dopamine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Other than maximizing entrance of levodopa into the brain, what does decarboxylase inhibitors do in relation to side effects of drug treatment for Parkinson’s?

A

Decarboxylase inhibitors ensure that side effects associated with increased peripheral concentrations of dopamine are lessened.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

You take levodopa PO, what is significant about the dosing (due to elimination half-time)?

A

GI absorption is efficient but has brief elimination half-time (1-3 hours) and requires frequent dosing intervals to maintain therapeutic levels.

30
Q

True or False

There is also an IV form of levodopa but it is not used bc the absorption rate is too quick?

A

False, no IV form of levodopa is available.

31
Q

What is important about the therapeutic benefits of Levodopa? Basically how long are you allowed to take drug therapy and why? (this is probably why they wait to treat symptoms)

A

Therapeutic benefits diminishes after 5- 10 years. May be d/t disease progression and continuing loss of nigrostriatal neurons with a capacity to store dopamine.

32
Q

Which NT can cross the BBB, Dopamine or L dopa?

A

L dopa (levodopa) can cross the BBB, NOT dopamine. (this is important bc if dopamine can not cross the BBB then it stays in place also, does not exit the CNS once there!)

33
Q

Tell me what has occurred in the situation below:
A patient has been in the hospital for 2 days with no PO medications given and has Parkinson’s dz. They are about to be taken to the OR for an emergency surgery. You notice upon your quick assessment they have all the text book symptoms of neuroleptic malignant- like syndrome, what is going on?

A

Abrupt d/c of levodopa may result in a precipitous return of symptoms of Parkinson’s disease and associated with neuroleptic malignant-like syndrome.

34
Q

True or False

Thus levodopa should be continued through the perioperative period?

A

True, due to return of symptoms if abruptly stopped.

35
Q

What happens to 95% of PO administered levodopa during initial passage through the liver?

A

rapidly decarboxylated to dopamine during the initial passage through the liver.

36
Q

Due to the amount of PO levodopa that decarboxylates to dopamine during first pass through the liver, what will you give in order to increase the fraction that can cross the BBB as levodopa?

A

an inhibitor of decarboxylase enzyme (think decarboxylase bad, you want to inhibit with parkinson’s)

37
Q

30 metabolites of levodopa are known (most excreted by the kidneys) and are converted to dopamine, a small amount are metabolized to what and what?

A

norepinehrine and epinephrine

this makes sense bc the natural progression of tyrosine to L-dopa to dopamine to norepi and then to epinephrine

38
Q

homovanilic acid comes from the metabolism of what?

A

dopamine

39
Q

Most common SE (in the first few weeks) with levodopa and dopamine agonists?

A

Nausea and hypotension

40
Q

Most common problems with long term therapy for Parkinson’s dz?

A 
Dyskinesia
Fluctuations in mobility
Increasing confusion 
Psychosis
These become more frequent after the 3 years
41
Q

If someone was just started (first few weeks) on parkinson’s treatment then what do you want to do for them during intubation?

A

They are likely to have nausea which could lead to vomiting, thus during intubation you will want to do a RSI and place an NG tube.
You may also want to give them lots of anti emetics for when they wake up.

42
Q

Urinary metabolites of levodopa can cause what?

A

false positive ketoacidosis tests

43
Q

What may you notice about the urine of a person who is being treated for Parkinson’s dz?

A

Metabolites color urine RED then BLACK upon exposure to air.

44
Q

If a patient with parkinson’s dz has an increase in BUN, what will you do, what do you know about this increase?

A

Transient increases in BUN may occur and can be controlled by increasing fluid intake.

45
Q

What test may show up positive for a Parkinson’s patient being treated pharmacologically? (think anemia)

A

May have a positive Coomb’s test: Test for antibodies in blood stream determining if the immune system is destroying the patient’s own blood cells causing anemia.

46
Q

What are some antipsychotic drugs do you NOT want to give to a patient who is being treated for Parkinson’s with Levodopa?

A

Butyrophenones and phenothiazines (antipsychotic drugs) can antagonize effects of dopamine and should not be given to Parkinson’s patients (known or suspected).

47
Q

What drug if given to a patient being treated with Levodopa can cause muscle rigidity and pulmonary edema?

A

Droperiodol

48
Q

What drug can produce parkinson’s like symptoms in a normal patient?

A

Droperiodol

49
Q

Would you want to give Metoclopramide with levodopa? Why?

A

Metoclopramide may also interfere with dopamine activity (reglan).

50
Q

What drug can Can exaggerate PNS and CNS effects of levodopa. Hypertension and hyperthermia are side effects with concurrent administrations?

A

Monoamine Oxidase Inhibitors

51
Q

What are two things that can happen if you give anticholinergic drugs with levodopa? (one is good, one is not so good)

A

Anticholinergic Drugs: Act synergistically with levodopa to improve certain symptoms of Parkinson’s disease especially tremor (GOOD)

Large doses of anticholinergics can slow gastric emptying such that absorption of levodopa from the GI tract is decreased. (not so good)

52
Q

Whats the big deal about Vitamin B and levodopa?

A

Pyridoxine (Vitamin B): in doses as a low as 5 mg can abolish the therapeutic efficacy of levodopa by enhancing the activity of pyridoxine-dependent dopa decarboxylase and thus increasing the metabolism of levodopa in the circulation before it can enter CNS.

53
Q

What vitamin do you not want to give to someone being treated with Levodopa?

A

Vitamin B

54
Q

What is Carbidopa and Benserazide?

A

Peripheral Decarboxylase Inhibitors

55
Q

What does Carbidopa and Benserazide do? (drug action or purpose for giving)

A

Allows more levodopa to escape metabolism into dopamine in the peripheral circulation and thus is more available to enter CNS

56
Q

What is diminished or absent in Parkinson’s patients treated with carbidopa and benserazide

A

N/V and cardiac dysrhythmias are diminished or absent

bc of less dopamine floating around peripherally I assume

57
Q

True or False

Carbidopa and Benserazide treats abnormal involuntary movements and psychiatric disturbances.

A

False, it DOES NOT treat abnormal involuntary movements and psychiatric disturbances.

58
Q

What are two combination drugs that are used for Parkinson’s dz, and what are their ratios?

A

Sinemet: levodopa and carbidopa in a 10:1 or 4:1

Madopar: levodopa and benserazide in a 4:1 ratio

59
Q

Whats significant about controlled release preparations of levodopa and carbidopa?

A

provide a more constant therapeutic effect but onset of action is slower and bioavailability is decreased compared with standard combinations.

60
Q

Does Carbidopa and Benserazide cross the BBB?

A

NO!

61
Q

Noncompetitive inhibitors of decarboxylase such as carbidopa and benserazide, if you give higher doses will that help even more?

A

Noncompetitive inhibitors of decarboxylase does not improve with progressively higher doses. (the more the better is not true here)

62
Q

If administered alone (Carbidopa and Benserazide) will they still have pharmacologic activity?

A

Lack pharmacologic activity when administered alone

63
Q

What two meds block COMT enzyme activity in the GI tract and why does it even matter to Parkinson’s patients?

A

Tolcapone and/ or Entacapone

it matters bc COMT is Partially responsible for peripheral breakdown of levodopa. Thus these drugs slows elimination of carbidopa-levodopa increasing the plasma concentration by 10-15%.

This then means the dose of carbidopa- levodopa daily needs to be decreased by 10-30% to avoid dyskinesias or other side effects of increased dopamine.

64
Q

What two drugs slow the elimination of carbidopa-levodopa thus increasing the plasma concentration by 10-15%?

A

Tolcapone or Entacapone

65
Q

Levodopa can cause dyskinesias and cause nausea and diarrhea if given with what two meds?

A

Tolcapone and Entacapone

66
Q

What medication is known to turn urine orange associated with Parkinson’s dz?

A

Entacapone

67
Q

What two meds associated with Parkinson’s dz can cause goosebumps?

A

Tolcapone and Entacapone

68
Q

Tolcapone and Entacapone would be considered what kind of drug?

A

Dopamine promoters

69
Q

Which dopamine promoter should have liver function tests done while you are using it? This drug has also been associated with rhabdo.

A

Tolcapone can cause hepatotoxicity (rare) and liver function tests need to be done. Associated also with rhabdomyolysis

70
Q

Which medications (name 5 of them) Do not require transformation or facilitated transport across the BBB.

A

Bromocriptine and Pergolide (tetracyclic ergot alkaloids)
Pramiperxole, ropinirole, and rotigotine (non ergot alkaloids)

Know as synthetic dopamine agonists

71
Q

Bromocriptine and pergolide:

Is the elimination half time longer or shorter than that for levodopa?

A

longer

72
Q

What synthetic dopamine agonist does the below describe:
GI absorption is rapid but incomplete
Extensive hepatic first-pass metabolism occurs and >90 of the metabolites are excreted in the bile. 10% unchanged in urine
0.5 mg to 1.0 mg is equivalent to 100 mg in combo with 25 mg of carbidopa or benserazide

A

Bromocriptine

SUM '20 - Pharm II (30 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions